Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for biotechnological production of organic acids and amino acids. 2006

Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
Institute of Molecular Microbiology and Biotechnology, Westfalian Wilhelms University Münster, 48149 Münster, Germany. wendisch@uni-muenster.de

Industrial microorganisms have been developed as biocatalysts to provide new or to optimize existing processes for the biotechnological production of chemicals from renewable plant biomass. Rational strain development by metabolic engineering is crucial to successful processes, and is based on efficient genetic tools and detailed knowledge of metabolic pathways and their regulation. This review summarizes recent advances in metabolic engineering of the industrial model bacteria Escherichia coli and Corynebacterium glutamicum that led to efficient recombinant biocatalysts for the production of acetate, pyruvate, ethanol, d- and l-lactate, succinate, l-lysine and l-serine.

UI MeSH Term Description Entries
D009930 Organic Chemicals A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form. Organic Chemical,Chemical, Organic,Chemicals, Organic
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies
D048230 Corynebacterium glutamicum A species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.

Related Publications

Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
February 2011, Applied microbiology and biotechnology,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
January 2011, Biotechnology advances,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
December 2021, Microbial cell factories,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
August 2019, Critical reviews in biotechnology,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
December 2014, Journal of biotechnology,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
September 2018, Microbial cell factories,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
August 2014, Nature communications,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
January 2014, Applied microbiology and biotechnology,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
December 2010, Applied and environmental microbiology,
Volker F Wendisch, and Michael Bott, and Bernhard J Eikmanns
February 2019, Applied microbiology and biotechnology,
Copied contents to your clipboard!